Anti-TIGIT Neutralizing Antibody 71340 from BPS Bioscience, Inc.

Product Specs
ItemAnti-TIGIT Neutralizing Antibody
CompanyBPS Bioscience, Inc.
Price $565.00Supplier Page View Company Product Page
Catalog Number71340
Quantity100 µg
Conjugate/TagUnconjugated
FormatAqueous buffer solution
ReactivityHuman
ApplicationsFunctional Assay/Study (FA)
Hosthuman
NCBI Full Gene NameT cell immunoreceptor with Ig and ITIM domains
NCBI Gene AliasesVSIG9, VSTM3, WUCAM
TypeAntibody
ClonalityMonoclonal

Add to Compare List

BPS Bioscience, Inc.

6405 Mira Mesa Blvd

Suite 100

San Diego, CA 92121

United States

Phone: 858-202-1401

Email: sales-team@bpsbioscience.com

Company Profile

Website: https://bpsbioscience.com/

(1) Tumor immune microenvironment reconstitution in patient-derived organoids enables therapy modeling for NSCLCCell Reports MethodsJune 15, 2026Enrique Podaza, Jared Capuano, Hui-Hsuan Kuo, Majd Al Assaad, Geoffrey Markowitz, M. Victoria Revuelta, John Nguyen, Adriana Irizarry, Hiranmayi Ravichandran, Sarah Ackermann, et al.human LAG3 (BLR027F),invitrogen,MA5-44249: RRID: AB_2926379 Mouse-anti human TIGIT,BPS Bioscience,71340: RRID: AB_2742063 Mouse-anti human PDL1(LY3300054),Eli Lilly,provided by Eli lilly Mouse-anti human

(2) The dual role of TIGIT in regulatory and effector T cells in chronic liver diseaseJHEP ReportsJune 1, 2025Amber G. Bozward, Scott P. Davies, Rémi Fiancette, Grace E. Wootton, Sian Faustini, Hin Fai Kwok, Naomi Richardson, Sean M. Morris, Kayani Kayani, Gary Middleton, et al.being co-cultured with CellTracker™ Green-labelled PHHs at a 1:2 ratio. A TIGIT neutralising antibody (#71340, BPS Bioscience, San Diego, California, USA) was added (5 μg/ml) to select wells, blocking TIGIT interactions.

(3) Glycan Structures in Osteosarcoma as Targets for Lectin-Based Chimeric Antigen Receptor ImmunotherapyInternational Journal of Molecular SciencesMay 14, 2024Nele Prasse, Charlotte Wessolowski, Ingo Müller, Kerstin Cornils, Anna-Katharina Frankeabsence or presence of different amounts of a human anti-TIGIT-neutralizing antibody (BPS Bioscience #71340) in a standard 3 h calcein release assay. In brief, effector cells were incubated with 1 × 104 calcein-labeled

(4) Targeting TIGIT for cancer immunotherapy: recent advances and future directionsBiomarker researchJanuary 16, 2024Zhang P, Liu X, Gu Z, Jiang Z, Zhao S, Song Y, Yu J.IgG2a)CD40 agonist (BioXCell; Clone FGK4.5/FGK45; Rat IgG2a),Pancreatic Cancer Solid tumors,"Anti-TIGIT (#71340, 5 μg/mL, BPS Biosciences) [68]",Not mentioned,CD8+ T cells from human gastric cancer tissues,Treatment

(5) GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancersGenome MedicineNovember 26, 2023Anuja Sathe, Carlos Ayala, Xiangqi Bai, Susan M. Grimes, Byrne Lee, Cindy Kin, Andrew Shelton, George Poultsides, Hanlee P. Jiμg/ml GITR agonist (BPS Bioscience, catalog #79053), 2 μg/ml TIGIT antagonist (BPS Bioscience, catalog #71340), or 6 μg/ml eBioscience Cell Stimulation Cocktail (500X) (Thermo Fisher Scientific). At 24 h, TSCs

(6) Clinical significance of CD8⁺ T cell immunoreceptor with Ig and ITIM domains⁺ in locally advanced gastric cancer treated with SOX regimen after D2 gastrectomyOncoimmunologyJanuary 1, 2019Tang W, Pan X, Han D, Rong D, Zhang M, Yang L, Ying J, Guan H, Chen Z, Wang X.T cell function assay CD8+ TIL Cells were divided into the control, SOX-treated, anti-TIGIT-treated (#71340, 5 ug/mL, BPS Biosciences), and SOX + anti-TIGIT-treated groups. For the proliferation assay, CD8+ TIL

Be the First to Write a Review!

Anti-TIGIT Neutralizing Antibody

Anti-TIGIT Neutralizing Antibody

Anti-TIGIT Neutralizing Antibody

Anti-TIGIT Neutralizing Antibody

Anti-TIGIT Neutralizing Antibody

Anti-TIGIT Neutralizing Antibody from BPS Bioscience, Inc.

Description

BPS Bioscience, Inc.

Citations (6)

Reviews

Anti-TIGIT Neutralizing Antibody from BPS Bioscience, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map